Abstract:BACKGROUND:Randomized controlled trials are considered the gold standard for evaluating experimental treatments but often require large sample sizes. Single-arm trials require smaller sample sizes but are subject to bias when using historical control data for comparative inferences. This article presents a Bayesian adaptive synthetic-control design that exploits historical control data to create a hybrid of a single-arm trial and a randomized controlled trial.METHODS:The Bayesian adaptive synthetic control design has two stages. In stage 1, a prespecified number of patients are enrolled in a single arm given the experimental treatment. Based on the stage 1 data, applying propensity score matching and Bayesian posterior prediction methods, the usefulness of the historical control data for identifying a pseudo sample of matched synthetic-control patients for making comparative inferences is evaluated. If a sufficient number of synthetic controls can be identified, the single-arm trial is continued. If not, the trial is switched to a randomized controlled trial. The performance of The Bayesian adaptive synthetic control design is evaluated by computer simulation.RESULTS:The Bayesian adaptive synthetic control design achieves power and unbiasedness similar to a randomized controlled trial but on average requires a much smaller sample size, provided that the historical control data patients are sufficiently comparable to the trial patients so that a good number of matched controls can be identified in the historical control data. Compared to a single-arm trial, The Bayesian adaptive synthetic control design yields much higher power and much smaller bias.CONCLUSION:The Bayesian adaptive synthetic-control design provides a useful tool for exploiting historical control data to improve the efficiency of single-arm phase II clinical trials, while addressing the problem of bias when comparing trial results to historical control data. The proposed design achieves power similar to a randomized controlled trial but may require a substantially smaller sample size.

Partially balanced nested block designs based on 2-associate-class association schemes for test-control comparisons

Tri-hierarchical incomplete block designs

Efficient Designs in Small Blocks for Comparing Consecutive Pairs of Treatments

Efficient Augmented Block Designs for Unreplicated Test Treatments Along with Replicated Controls

Design-based Causal Inference for Balanced Incomplete Block Designs

Efficient Balanced Treatment Assignments for Experimentation

Optimal Paired Comparison Block Designs

Balanced Incomplete Latin Square Designs

Optimal Designs For Two Non-Interactive Treatment

Uniformity of Incomplete Block Designs

Nonparametric Multiple Comparison Procedures for Unbalanced One-Way Factorial Designs

Asymptotic properties of doubly adaptive biased coin designs for multitreatment clinical trials

Optimal BIBD-extended designs

BASIC: A Bayesian Adaptive Synthetic-Control Design for Phase II Clinical Trials.

E- and R-optimality of block designs for treatment-control comparisons

Testing Equality of Treatments under an Incomplete Block Crossover Design with Ordinal Responses

Construction of three-associate class PBIB designs by generating a set of square matrices

On Construction of Optimal Two-Level Designs with Multi Block Variables

Bayesian Optimal Interval Design: A Simple and Well-Performing Design for Phase I Oncology Trials.

Multivariate Tie-breaker Designs

Nearly Random Designs with Greatly Improved Balance